Close

Publications

Prevalence of curable sexually transmitted and reproductive tract infections among pregnant women attending antenatal care in Nchelenge, Zambia.
CHAPONDA, M; Chaponda, E; Mwanza, S; Chikwanda, E; Hachizovu, S; Nambozi, M; Gwasupika, J; Daka, V; Ghilardi, L; Bruce, J; CHANDRAMOHAN, D; CHICO, RM;
2022
(2022).
Malaria infection and antibody responses to single-dose HPV vaccination: Results from a dose-reduction immunogenicity trial (the DoRIS trial) among Tanzanian school girls.
WATSON-JONES, D;
2022
(2022).
Memory B-cell responses to different HPV vaccine regimes: Results from a dose-reduction randomised open-label trial (DoRIS) among Tanzanian school girls up to thirty-six months post-vaccination.
WATSON-JONES, D;
2022
(2022).
Immunobridging single-dose HPV vaccine in Tanzanian girls (DoRIS trial) to Kenyan women in whom single-dose efficacy has been demonstrated (KEN SHE trials).
WATSON-JONES, D;
2022
(2022).
Amuge, P; Lugemwa, A; Wynne, B; Mujuru, HA; Violari, A; Kityo, CM; Archary, M; Variava, E; White, E; Turner, RM; Shakeshaft, C; Ali, S; Nathoo, KJ; Atwine, L; Liberty, A; Bbuye, D; Kaudha, E; Mngqibisa, R; Mosala, M; Mumbiro, V; Nanduudu, A; Ankunda, R; Maseko, L; Kekitiinwa, AR; Giaquinto, C; ... ODYSSEY Trial Team,
2022
The Lancet HIV, (2022).9 9 10.1016/S2352-3018(22)00163-1.
Hamon, JK; Kambanje, M; Pryor, S; Kaponda, AS; Mwale, E; WEBSTER, J; BURCHETT, HE D; MAYHEW, SH;
2022
SSM - Qualitative Research in Health, (2022).2, 10.1016/j.ssmqr.2022.100159.
Gurdasani, D; Pagel, C; MCKEE, M; Michie, S; Greenhalgh, T; Yates, C; Scally, G; Ziauddeen, H;
2022
BMJ, (2022).378, 10.1136/bmj-2022-071234.
Bougouma, EC; Palacpac, NM Q; Tiono, AB; Nebie, I; Ouédraogo, A; Houard, S; Yagi, M; Coulibaly, SA; Diarra, A; Tougan, T; Ouedraogo, AZ; Soulama, I; Arisue, N; Yaro, JB; D'Alessio, F; Leroy, O; COUSENS, S; Horii, T; Sirima, SB;
2022
Frontiers in immunology, (2022).13, 10.3389/fimmu.2022.978591.